The Importance of Screening Tests and Amniocentesis in Approach to Pregnant Women Over the Age of Thirty-Five

Basit Öğe Kaydı
dc.authoridsezer, salim/0000-0003-1287-4306
dc.authoridBolluk, Gokhan/0000-0002-3506-6806
dc.contributor.authorSezer, Salim
dc.contributor.authorBestel, Melih
dc.contributor.authorBolluk, Gokhan
dc.contributor.authorGezdirici, Alper
dc.date.accessioned2025-03-26T17:34:44Z
dc.date.available2025-03-26T17:34:44Z
dc.date.issued2022
dc.departmentİstanbul Esenyurt Üniversitesi
dc.description.abstractObjective: Our goal was to evaluate the approach to the increased risk of fetal chromosomal anomaly in pregnant women over thirty-five years of Methods: We retrospectively examined pregnant women over the age of 35 who underwent interventional procedures for fetal karyotype analysis in the Perinatology Clinic of University of Health Sciences Turkey Kanuni Sultan Suleyman Training and Research Hospital. Regardless of the indication for karyotype analysis, pregnant women over the age of 35 who underwent karyotype analysis were included in the study. Results: Abnormal karyotype was detected in 76 (8.7%) of a total of 867 pregnant women examined in the study. Of 76 abnormal karyotypes, 51 were found as trisomy 21 (67.7%), 15 as trisomy 18 (21%), and 3 as trisomy 13 (4%). Three fetal karyotype analyzes revealed Turner syndrome (4%), 1 Klinefelter syndrome (1.3%), 2 mosaic trisomy 21 (2.6%) and 1 mosaic Turner syndrome (1.3%). In the patients who underwent interventional procedures primarily because of advanced maternal age, abnormal karyotype was detected in 6 (1.9%) of them. The rates of abnormal karyotype results for double, triple and quadruple tests were 6.4%, 1.9% and 5.8%, respectively. Conclusion: The use of a triple test has no definite impact on the results of pregnant women of older age. When there is no fetal abnormality in the ultrasound, double and quadruple tests may be requested or since the fetal death rate is minimal in amniocentesis, it can be recommended directly without performing any screening tests in pregnant women with older age.
dc.identifier.doi10.4274/jarem.galenos.2022.16878
dc.identifier.endpage158
dc.identifier.issn2146-6505
dc.identifier.issn2147-1894
dc.identifier.issue3
dc.identifier.scopusqualityN/A
dc.identifier.startpage155
dc.identifier.trdizinid1172377
dc.identifier.urihttps://doi.org/10.4274/jarem.galenos.2022.16878
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1172377
dc.identifier.urihttps://hdl.handle.net/20.500.14704/865
dc.identifier.volume12
dc.identifier.wosWOS:000908748300001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherGalenos Publ House
dc.relation.ispartofJournal of Academic Research in Medicine-Jarem
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250326
dc.subjectAdvanced maternal age; amniocentesis; Down sendrome; chromosomal anomaly; karyotype analysis
dc.titleThe Importance of Screening Tests and Amniocentesis in Approach to Pregnant Women Over the Age of Thirty-Five
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Sağlık Bilimleri Fakültesi Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu